rood blauwe elepsis logo Belegger.nl

Sopheon Terug naar discussie overzicht

Weekdraadje 37 - 2011

26 Posts
Pagina: «« 1 2 | Laatste | Omlaag ↓
  1. [verwijderd] 15 september 2011 20:28
    Drive Ideas to Market: Enhance Your Idea-to-Launch Process – Move to the Next Generation
    October 17-18, 2011
    Dornbirn, Austria

    Presented by Dr. Robert Cooper, one of the world’s leading authorities in the field of innovation, technology and new product development, this seminar is designed for executives and senior managers responsible for maximizing the returns on their innovation efforts. By attending this event, you will learn how to:

    Uncover effective strategies to streamline your idea-to-launch process, making it more flexible and adaptive
    Discover how to incorporate voice of the customer into your NPD process
    Maximize the value of your portfolio through more effective resource allocation and selection of the right projects
    Engage and inspire your team to live the Stage-Gate® principles deliberately
    Sopheon will be exhibiting its end-to-end solutions for strategic planning, idea development, and gated process execution.

    www.five-is-innovation.com/cooper/fol...

    Nico
  2. Bertus S 15 september 2011 22:29
    Klopt Frank, Red paper Q3-2011 is not available on the server.

    Heb Gerard al een mailtje gestuurd, zie je mailbox.

    Bertus S.
  3. [verwijderd] 16 september 2011 16:01
    quote:

    Bertus S schreef op 15 september 2011 22:29:

    Klopt Frank, Red paper Q3-2011 is not available on the server.

    Heb Gerard al een mailtje gestuurd, zie je mailbox.

    Bertus S.
    Bertus,

    bedankt weer voor je moeite/hulp.

    Frank.
  4. forum rang 4 Ed Verbeek 16 september 2011 20:18
    quote:

    Bertus S schreef op 15 september 2011 22:03:

    www.sopheon.com/Portals/1/pdf/SocialM...

    Bertus S.
    Bedankt voor het plaatsen Bertus.
    Ziet er weer veelbelovend uit:

    "In summary, Vision Strategist is helping BAE Systems to:
    • Identify important business opportunities, as well as the level and timing of funding requirements
    • Better communicate forward-looking plans and understand the relevance of plan information at any point in time
    • Create tighter alignment between R&D investments, program requirements and market drivers
    • Maintain a well-defined, standardized roadmapping process across the organization."
26 Posts
Pagina: «« 1 2 | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.097
AB InBev 2 5.525
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.867
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.772
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 192
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.764
Aedifica 3 923
Aegon 3.258 322.961
AFC Ajax 538 7.088
Affimed NV 2 6.297
ageas 5.844 109.896
Agfa-Gevaert 14 2.051
Ahold 3.538 74.343
Air France - KLM 1.025 35.220
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.046
Alfen 16 25.021
Allfunds Group 4 1.510
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 406
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.826
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.503
AMG 971 134.010
AMS 3 73
Amsterdam Commodities 305 6.735
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 15.027
Apollo Alternative Assets 1 17
Apple 5 384
Arcadis 252 8.787
Arcelor Mittal 2.034 320.848
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.333
Aroundtown SA 1 220
Arrowhead Research 5 9.747
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.445
ASML 1.766 108.747
ASR Nederland 21 4.502
ATAI Life Sciences 1 7
Atenor Group 1 521
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.690
Axsome Therapeutics 1 177
Azelis Group 1 66
Azerion 7 3.412